S 5571In Committee
A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.
Introduced September 28, 2026
Summary
Timeline
Read twice and referred to the Committee on Finance.
Introduced in Senate
See how this bill affects you
Enter your details to get a personalized impact estimate.
Check your impact